SPAC1039.02 Antibody

What is SPAC1039.02 and why is it important in S. pombe research?

SPAC1039.02 is a gene in Schizosaccharomyces pombe (fission yeast) that appears to be part of the Tel1R cluster and is regulated during nitrogen depletion . Studies have shown that genes in this cluster undergo pronounced nucleosome loss during induction by nitrogen withdrawal and move from the nuclear periphery to a more internal localization upon induction . Understanding SPAC1039.02's function may provide insights into how fission yeast responds to nutrient stress, particularly nitrogen deprivation.

What are the key specifications of commercially available SPAC1039.02 antibodies?

Based on available data, SPAC1039.02 antibody (e.g., CSB-PA892514XA01SXV) typically has the following specifications:

These specifications are typical for research-grade antibodies targeting S. pombe proteins .

What are recommended protocols for Western blot analysis using SPAC1039.02 antibody?

Based on standard protocols used with S. pombe proteins, a Western blot protocol for SPAC1039.02 would typically include:

• Sample preparation: Prepare denatured whole-cell extracts as described in relevant literature for fission yeast .

• Protein separation: Resolve approximately 50 μg of protein on 4-20% Tris-glycine gels.

• Transfer: Transfer proteins to a nitrocellulose membrane using a dry blotting transfer system.

• Blocking: Block the membrane in 5% (wt/vol) nonfat milk in Tris-buffered saline with 0.1% (vol/vol) Tween 20.

• Primary antibody incubation: Incubate with SPAC1039.02 antibody at an empirically determined dilution (typically 1:1000 to 1:5000).

• Secondary antibody incubation: Use an IRDye-conjugated secondary antibody (such as anti-rabbit IgG).

• Imaging: Image the membrane on an appropriate scanner system .

How can I optimize chromatin immunoprecipitation (ChIP) experiments with SPAC1039.02 antibody?

For ChIP assays investigating SPAC1039.02 binding to chromatin during nitrogen depletion responses:

• Cell preparation: Culture approximately 700 OD600 units of cells and process them in 14 equal aliquots.

• Cross-linking: Cross-link proteins to DNA using 1% formaldehyde for 15-20 minutes at room temperature.

• Chromatin preparation: Lyse cells and sonicate chromatin to fragments of 200-600 bp using a Bioruptor for approximately 240 seconds at high power (250W) in ice-cold water .

• Verification: Verify fragment size by running sheared DNA on a 2% agarose gel.

• Immunoprecipitation: Incubate chromatin with SPAC1039.02 antibody pre-bound to protein A/G magnetic beads.

• Washing: Perform stringent washes to remove non-specific binding.

• Elution and reversal of cross-links: Elute complexes with 10 mM Tris (pH 8), 1 mM EDTA, and 1% SDS at 70°C, then reverse cross-links.

• DNA recovery: Purify DNA and analyze by qPCR .

How can I validate the specificity of SPAC1039.02 antibody?

To confirm antibody specificity, use the following validation approaches:

• Genetic validation: Use a knockout strain (SPAC1039.02Δ) as a negative control, which should show no signal.

• Overexpression control: Compare signal between wild-type and strains overexpressing SPAC1039.02, which should show increased signal intensity .

• Peptide competition assay: Pre-incubate the antibody with recombinant SPAC1039.02 protein immobilized on beads and use the unbound fraction for Western blot, which should show abolished signal compared to control (incubation with beads alone) .

• Mass spectrometry verification: For immunoprecipitation experiments, confirm the identity of the pulled-down protein by mass spectrometry .

These validation approaches are essential to establish that your antibody specifically recognizes SPAC1039.02 and not other S. pombe proteins.

What techniques can be used to study SPAC1039.02 protein modifications?

To investigate potential post-translational modifications of SPAC1039.02:

• Mobility shift analysis: Examine protein mobility on SDS-PAGE, which may reveal modifications such as farnesylation (as demonstrated with other S. pombe proteins) .

• Temperature-sensitive mutants: Use temperature-sensitive mutants of modification enzymes (like cpp1-1, which affects farnesylation) to evaluate changes in SPAC1039.02 modification status .

• Mass spectrometry analysis: After immunoprecipitation, use techniques similar to those described in the search results: denaturation, reduction, alkylation, and trypsin digestion followed by analysis on a triphasic MudPIT column connected to an HPLC pump and mass spectrometer .

• Phosphorylation analysis: If SPAC1039.02 is regulated by nitrogen depletion, examine potential phosphorylation events using phospho-specific antibodies or phosphatase treatments.

What are common issues with SPAC1039.02 antibody experiments and how can they be resolved?

How can I assess the quality of my SPAC1039.02 antibody for specific applications?

For quality assessment, perform these validation experiments:

• Titration experiment: Test serial dilutions (e.g., 1:500, 1:1000, 1:5000) to determine optimal antibody concentration for each application.

• Positive control expression: Express tagged SPAC1039.02 (e.g., FLAG-tagged) and perform parallel detection with both SPAC1039.02 antibody and anti-FLAG antibody to compare specificity profiles .

• Cross-reactivity panel: Test the antibody against lysates from related species or strains to evaluate potential cross-reactivity.

• Batch consistency test: When receiving new antibody batches, compare performance to previous lots using standardized positive controls.

How can SPAC1039.02 antibody be used to study protein-protein interactions?

To investigate SPAC1039.02 protein interactions:

• Co-immunoprecipitation: Use SPAC1039.02 antibody for pulldown experiments followed by mass spectrometry to identify interacting partners.

• Proximity labeling: Combine with BioID or APEX approaches by creating fusion proteins and using the antibody to confirm expression.

• Two-hybrid verification: After identifying potential interactors through yeast two-hybrid screens, verify interactions by co-immunoprecipitation using the SPAC1039.02 antibody.

• Sequential immunoprecipitation: For complex purification, use a strategy similar to that described in search result , with sequential enrichment steps, TCA precipitation, and mass spectrometry analysis.

What experimental approaches can determine SPAC1039.02 expression levels under different conditions?

To examine SPAC1039.02 expression under different experimental conditions:

• Quantitative Western blotting: Use the antibody with appropriate loading controls (e.g., act1) to quantify relative protein levels.

• Flow cytometry: For single-cell analysis, fix and permeabilize cells before antibody staining.

• Cellular fractionation: Combine with Western blotting to examine subcellular localization changes under different conditions.

• Nitrogen depletion studies: Given SPAC1039.02's regulation during nitrogen stress, compare protein levels between nitrogen-rich and nitrogen-depleted conditions using time course experiments .

• Gene expression correlation: Combine protein-level data with qRT-PCR measurements (similar to methods in search result ) to understand transcriptional and post-transcriptional regulation.

How can SPAC1039.02 antibody be integrated with high-throughput screening approaches?

For high-throughput applications:

• Antibody microarrays: Spot SPAC1039.02 antibody onto arrays for parallel processing of multiple samples.

• Automated Western blotting: Implement the antibody in capillary-based protein analysis systems for higher throughput.

• Pooled genetic screens: Use the antibody to detect SPAC1039.02 levels in cells with different genetic perturbations.

• Active learning approaches: Similar to methods described for antibody-antigen binding prediction , develop machine learning models to predict conditions affecting SPAC1039.02 expression or localization.

How can SPAC1039.02 antibody be utilized in studying protein-DNA interactions during nitrogen stress response?

For studying SPAC1039.02's potential role in chromatin dynamics during nitrogen stress:

• ChIP-seq analysis: Perform chromatin immunoprecipitation followed by next-generation sequencing to map genome-wide binding sites, similar to approaches used to study Atf1-Pcr1 binding sites .

• DNA-protein interaction mapping: Use techniques like EMSA with the antibody for supershift assays to confirm specific DNA-protein interactions.

• Genome-wide localization changes: Combine with fluorescence microscopy to examine changes in nuclear localization during nitrogen depletion, as genes in the Tel1R cluster have been shown to move from the nuclear periphery to a more internal location .

• Nucleosome positioning analysis: Use the antibody in conjunction with MNase digestion to examine how SPAC1039.02 may influence the pronounced nucleosome loss observed during nitrogen depletion .

How can I develop improved monoclonal antibodies against SPAC1039.02?

To develop higher-quality monoclonal antibodies:

• Epitope selection: Identify unique, conserved, and accessible regions of SPAC1039.02 using structural predictions or homology modeling.

• Screening methodology: Implement high-throughput single-cell sequencing of B cells as described in search result to identify optimal antibody sequences.

• Antibody engineering: Apply structure-based design principles, potentially using molecular docking and alphafold2 methods similar to those described for SpA5 antibody development .

• Validation pipeline: Develop a comprehensive validation strategy including affinity measurements (KD determination), specificity testing, and functional assays.

What considerations should be made when adapting SPAC1039.02 antibody for use in emerging single-cell analysis techniques?

For single-cell applications:

• Antibody conjugation: Carefully select fluorophores or barcodes that minimize background in S. pombe experiments.

• Fixation optimization: Test multiple fixation protocols to ensure epitope preservation without compromising cell integrity.

• Multiplexing strategies: Develop protocols for co-detection with other fission yeast proteins, considering potential cross-reactivity.

• Signal amplification: For low-abundance detection, implement enzymatic amplification systems or tyramide signal amplification.

• Validation in single cells: Verify antibody performance using strains with known expression patterns or tagged reference proteins.

How might SPAC1039.02 antibody contribute to understanding chromatin dynamics during nutrient stress?

Building on findings that SPAC1039.02 is part of a gene cluster regulated during nitrogen depletion :

• Chromatin state mapping: Use the antibody in combination with histone modification antibodies to correlate SPAC1039.02 localization with specific chromatin states.

• Nuclear organization studies: Combine immunofluorescence with genomic approaches to understand how SPAC1039.02 contributes to nuclear reorganization during stress.

• Transcription factor interactions: Investigate potential relationships between SPAC1039.02 and transcription factors like Atf1 and Pcr1, which are essential for maltose utilization in S. pombe .

• Comparative analysis: Examine SPAC1039.02 behavior across different nutritional stress conditions beyond nitrogen depletion.

What role might computational approaches play in improving SPAC1039.02 antibody research?

Computational methods can enhance SPAC1039.02 research:

• Epitope prediction: Use machine learning algorithms to predict optimal antibody binding sites, similar to approaches used for antigen-antibody binding prediction .

• Active learning strategies: Implement the active learning approaches described in search result to efficiently design experiments that maximize information gain.

• Structure-function prediction: Apply AlphaFold2 modeling (as used in antibody research ) to predict SPAC1039.02 structure and potential interaction surfaces.

• Data integration platforms: Develop comprehensive databases similar to AACDB (Antigen-Antibody Complex Database) specifically for S. pombe research, integrating antibody validation data with functional genomics.